BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bökkerink GM, de Graaf EJ, Punt CJ, Nagtegaal ID, Rütten H, Nuyttens JJ, van Meerten E, Doornebosch PG, Tanis PJ, Derksen EJ. The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery. BMC Surg. 2011;11:34. [PMID: 22171697 DOI: 10.1186/1471-2482-11-34] [Cited by in Crossref: 63] [Cited by in F6Publishing: 44] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Tchelebi LT, Romesser PB, Feuerlein S, Hoffe S, Latifi K, Felder S, Chuong MD. Magnetic Resonance Guided Radiotherapy for Rectal Cancer: Expanding Opportunities for Non-Operative Management. Cancer Control 2020;27:1073274820969449. [PMID: 33118384 DOI: 10.1177/1073274820969449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zinicola R, Hill J, Fiocca R. Surgery for colorectal polyps: histological features, current indications, critical points, future perspective and ongoing studies. Colorectal Dis 2015;17 Suppl 1:52-60. [PMID: 25511862 DOI: 10.1111/codi.12822] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Stijns RCH, Tromp MR, Hugen N, de Wilt JHW. Advances in organ preserving strategies in rectal cancer patients. Eur J Surg Oncol. 2018;44:209-219. [PMID: 29275912 DOI: 10.1016/j.ejso.2017.11.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
4 Chawla S, Katz AW, Rauh SM, Monson JRT. Can Surgery be Avoided After Preoperative Chemoradiation for Rectal Cancer in the Era of Organ Preservation? Current Review of Literature. American Journal of Clinical Oncology 2015;38:534-40. [DOI: 10.1097/coc.0000000000000122] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Buijsen J, van Stiphout RG, Menheere PP, Lammering G, Lambin P. Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: A prospective, hypothesis driven study on patients with locally advanced rectal cancer. Radiotherapy and Oncology 2014;111:237-42. [DOI: 10.1016/j.radonc.2014.03.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
6 Teo M, Sebag-montefiore D, Donnellan C. Prevention and Management of Radiation-induced Late Gastrointestinal Toxicity. Clinical Oncology 2015;27:656-67. [DOI: 10.1016/j.clon.2015.06.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
7 Russo S, Blackstock AW, Herman JM, Abdel-Wahab M, Azad N, Das P, Goodman KA, Hong TS, Jabbour SK, Jones WE 3rd, Konski AA, Koong AC, Kumar R, Rodriguez-Bigas M, Small W Jr, Thomas CR Jr, Suh WW. ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer. Am J Clin Oncol 2015;38:520-5. [PMID: 26371522 DOI: 10.1097/COC.0000000000000197] [Reference Citation Analysis]
8 Smart CJ, Cunningham C, Bach SP. Transanal endoscopic microsurgery. Best Pract Res Clin Gastroenterol. 2014;28:143-157. [PMID: 24485262 DOI: 10.1016/j.bpg.2013.11.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
9 Pyo DH, Choi JY, Lee WY, Yun SH, Kim HC, Huh JW, Park YA, Shin JK, Cho YB. A Nomogram for Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy Using Semiquantitative Parameters Derived From Sequential PET/CT in Locally Advanced Rectal Cancer. Front Oncol 2021;11:742728. [PMID: 34676170 DOI: 10.3389/fonc.2021.742728] [Reference Citation Analysis]
10 Chen H, Shi L, Nguyen KNB, Monjazeb AM, Matsukuma KE, Loehfelm TW, Huang H, Qiu J, Rong Y. MRI Radiomics for Prediction of Tumor Response and Downstaging in Rectal Cancer Patients after Preoperative Chemoradiation. Adv Radiat Oncol 2020;5:1286-95. [PMID: 33305090 DOI: 10.1016/j.adro.2020.04.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Burbach JP, Verkooijen HM, Intven M, Kleijnen JP, Bosman ME, Raaymakers BW, van Grevenstein WM, Koopman M, Seravalli E, van Asselen B, Reerink O. RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial. Trials 2015;16:58. [PMID: 25888548 DOI: 10.1186/s13063-015-0586-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.7] [Reference Citation Analysis]
12 Shapiro J, van Hagen P, Lingsma HF, Wijnhoven BP, Biermann K, ten Kate FJ, Steyerberg EW, van der Gaast A, van Lanschot JJ; CROSS Study Group. Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer. Ann Surg. 2014;260:807-813; discussion 813-814. [PMID: 25379852 DOI: 10.1097/sla.0000000000000966] [Cited by in Crossref: 43] [Cited by in F6Publishing: 15] [Article Influence: 6.1] [Reference Citation Analysis]
13 Phang PT, Wang X. Current controversies in neoadjuvant chemoradiation of rectal cancer. Surg Oncol Clin N Am. 2014;23:79-92. [PMID: 24267167 DOI: 10.1016/j.soc.2013.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
14 Rawat N, Evans MD. Paradigm shift in the management of rectal cancer. Indian J Surg 2014;76:474-81. [PMID: 25614723 DOI: 10.1007/s12262-014-1089-3] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Vitelli CE, Stipa F, De Paula U. Is a policy of watch and wait after a complete response following neoadjuvant treatment for locally advanced rectal adenocarcinoma justified? Should we reset the limit? Updates Surg 2014;66:7-8. [PMID: 24288010 DOI: 10.1007/s13304-013-0239-7] [Reference Citation Analysis]
16 Vignali A, Nardi PD. Multidisciplinary treatment of rectal cancer in 2014: Where are we going? World J Gastroenterol 2014; 20(32): 11249-11261 [PMID: 25170209 DOI: 10.3748/wjg.v20.i32.11249] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
17 Vendrely V, Denost Q, Amestoy F, Célérier B, Smith D, Rullier A, Rullier É. [Organ preserving strategies for rectal cancer treatment]. Cancer Radiother 2015;19:404-9. [PMID: 26278990 DOI: 10.1016/j.canrad.2015.05.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
18 Cozzi MR, Lauretta A, Vettori R, Steffan A. Acquired factor XII deficiency following transanal excision of rectal lesion by transanal minimally invasive surgery (TAMIS): a case report and literature review. World J Surg Oncol 2018;16:115. [PMID: 29921296 DOI: 10.1186/s12957-018-1410-x] [Reference Citation Analysis]
19 Bosch SL, Vermeer TA, West NP, Swellengrebel HAM, Marijnen CAM, Cats A, Verhoef C, van Lijnschoten I, de Wilt JHW, Rutten HJ, Nagtegaal ID. Clinicopathological characteristics predict lymph node metastases in ypT0-2 rectal cancer after chemoradiotherapy. Histopathology 2016;69:839-48. [DOI: 10.1111/his.13008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
20 Shen L, van Soest J, Wang J, Yu J, Hu W, Gong YU, Valentini V, Xiao Y, Dekker A, Zhang Z. Validation of a rectal cancer outcome prediction model with a cohort of Chinese patients. Oncotarget 2015;6:38327-35. [PMID: 26413811 DOI: 10.18632/oncotarget.5195] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
21 Papamichael D, Audisio RA, Glimelius B, de Gramont A, Glynne-Jones R, Haller D, Köhne CH, Rostoft S, Lemmens V, Mitry E. Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann Oncol. 2015;26:463-476. [PMID: 25015334 DOI: 10.1093/annonc/mdu253] [Cited by in Crossref: 197] [Cited by in F6Publishing: 165] [Article Influence: 24.6] [Reference Citation Analysis]
22 Linter Kapišinská M, Hovorková E, Závalová V, Šubrt Z, Kuneš M, Ferko A. Distribution of metastases in mesorectum is unpredictable: Metastases do not respect tumor localization even in small non-circumferential rectal cancers. European Journal of Surgical Oncology 2018;44:87-92. [DOI: 10.1016/j.ejso.2017.11.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Stijns RCH, de Graaf EJR, Punt CJA, Nagtegaal ID, Nuyttens JJME, van Meerten E, Tanis PJ, de Hingh IHJT, van der Schelling GP, Acherman Y, Leijtens JWA, Bremers AJA, Beets GL, Hoff C, Verhoef C, Marijnen CAM, de Wilt JHW; CARTS Study Group. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study. JAMA Surg. 2019;154:47-54. [PMID: 30304338 DOI: 10.1001/jamasurg.2018.3752] [Cited by in Crossref: 66] [Cited by in F6Publishing: 49] [Article Influence: 22.0] [Reference Citation Analysis]
24 Baatrup G, Qvist N. Local resection of early rectal cancer. APMIS 2014;122:715-22. [PMID: 25046201 DOI: 10.1111/apm.12292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Kudou M, Nakanishi M, Kuriu Y, Murayama Y, Arita T, Kishimoto M, Konishi E, Goto M, Yamada K, Otsuji E. Value of intra-tumor heterogeneity evaluated by diffusion-weighted MRI for predicting pathological stages and therapeutic responses to chemoradiotherapy in lower rectal cancer. J Cancer 2020;11:168-76. [PMID: 31892983 DOI: 10.7150/jca.38354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Morino M, Allaix ME. Transanal endoscopic microsurgery: what indications in 2013? Gastroenterol Rep (Oxf). 2013;1:75-84. [PMID: 24759812 DOI: 10.1093/gastro/got012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
27 Buckley H, Wilson C, Ajithkumar T. High-Dose-Rate Brachytherapy in the Management of Operable Rectal Cancer: A Systematic Review. Int J Radiat Oncol Biol Phys 2017;99:111-27. [PMID: 28816137 DOI: 10.1016/j.ijrobp.2017.05.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
28 Lee NK, Kim DY, Kim SY, Oh JH, Park W, Choi DH, Nam TK, Lee KJ. Clinical outcomes of local excision following preoperative chemoradiotherapy for locally advanced rectal cancer. Cancer Res Treat 2014;46:158-64. [PMID: 24851107 DOI: 10.4143/crt.2014.46.2.158] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
29 Rombouts AJM, Al-Najami I, Abbott NL, Appelt A, Baatrup G, Bach S, Bhangu A, Garm Spindler KL, Gray R, Handley K, Kaur M, Kerkhof E, Kronborg CJ, Magill L, Marijnen CAM, Nagtegaal ID, Nyvang L, Peters FP, Pfeiffer P, Punt C, Quirke P, Sebag-Montefiore D, Teo M, West N, de Wilt JHW; for STAR-TREC Collaborative Group. Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study. BMJ Open. 2017;7:e019474. [PMID: 29288190 DOI: 10.1136/bmjopen-2017-019474] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 8.2] [Reference Citation Analysis]
30 Melosky B, Popat S, Gandara DR. An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic Approach. Clinical Lung Cancer 2018;19:42-50. [DOI: 10.1016/j.cllc.2017.05.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Ceelen WP. Progress in rectal cancer treatment. ISRN Gastroenterol 2012;2012:648183. [PMID: 22970381 DOI: 10.5402/2012/648183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
32 Rombouts AJM, Hugen N, Verhoeven RHA, Elferink MAG, Poortmans PMP, Nagtegaal ID, de Wilt JHW. Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients. Eur J Surg Oncol 2018;44:1018-24. [PMID: 29678303 DOI: 10.1016/j.ejso.2018.03.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
33 Léonard D, Remue C, Kartheuser A. The transanal endoscopic microsurgery procedure: standards and extended indications. Dig Dis. 2012;30 Suppl 2:85-90. [PMID: 23207938 DOI: 10.1159/000342033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
34 Waage JE, Bach SP, Pfeffer F, Leh S, Havre RF, Ødegaard S, Baatrup G. Combined endorectal ultrasonography and strain elastography for the staging of early rectal cancer. Colorectal Dis. 2015;17:50-56. [PMID: 25176033 DOI: 10.1111/codi.12764] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
35 Flexer SM, Durham-Hall AC, Steward MA, Robinson JM. TEMS: results of a specialist centre. Surg Endosc. 2014;28:1874-1878. [PMID: 24414462 DOI: 10.1007/s00464-013-3407-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
36 Allaix ME, Fichera A. Modern rectal cancer multidisciplinary treatment: the role of radiation and surgery. Ann Surg Oncol. 2013;20:2921-2928. [PMID: 23604783 DOI: 10.1245/s10434-013-2966-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
37 Melotti G, De Antoni E, Habr-Gama A, Minicozzi A. Management of distal rectal cancer: results from a national survey. Updates Surg 2013;65:43-52. [PMID: 23335049 DOI: 10.1007/s13304-012-0192-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
38 Bökkerink GMJ, van der Wilt GJ, de Jong D, van Krieken HHJM, Bleichrodt RP, de Wilt JHW, Bremers AJA. Value of macrobiopsies and transanal endoscopic microsurgery in the histological work-up of rectal neoplasms: A retrospective study. World J Gastrointest Oncol 2017; 9(6): 251-256 [PMID: 28656075 DOI: 10.4251/wjgo.v9.i6.251] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
39 González JEB, Lavernia HC, Fraga JGP, Lemus SQ. Long-term outcomes of transanal endoscopic microsurgery for clinical complete response after neoadjuvant treatment in T2-3 rectal cancer. Surg Endosc 2021. [PMID: 34231071 DOI: 10.1007/s00464-021-08583-y] [Reference Citation Analysis]
40 Audisio RA, Papamichael D. Treatment of colorectal cancer in older patients. Nat Rev Gastroenterol Hepatol. 2012;9:716-725. [PMID: 23045000 DOI: 10.1038/nrgastro.2012.196] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
41 Azizian A, Kramer F, Jo P, Wolff HA, Beißbarth T, Skarupke R, Bernhardt M, Grade M, Ghadimi BM, Gaedcke J. Preoperative Prediction of Lymph Node Status by Circulating Mir-18b and Mir-20a During Chemoradiotherapy in Patients with Rectal Cancer. World J Surg. 2015;39:2329-2335. [PMID: 25990502 DOI: 10.1007/s00268-015-3083-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
42 Morino M, Risio M, Bach S, Beets-tan R, Bujko K, Panis Y, Quirke P, Rembacken B, Rullier E, Saito Y, Young-fadok T, Allaix ME. Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surg Endosc 2015;29:755-73. [DOI: 10.1007/s00464-015-4067-3] [Cited by in Crossref: 75] [Cited by in F6Publishing: 54] [Article Influence: 10.7] [Reference Citation Analysis]
43 Kim NK, Kim MS, Al-Asari SF. Update and debate issues in surgical treatment of middle and low rectal cancer. J Korean Soc Coloproctol 2012;28:230-40. [PMID: 23185702 DOI: 10.3393/jksc.2012.28.5.230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
44 Shen L, Sun Y, Zhang H, Zhang J, Deng W, Wang Y, Yao Y, Yang L, Zhu J, Tong T, Liang L, Zhang Z. T3 subclassification using the EMD/mesorectum ratio predicts neoadjuvant chemoradiation outcome in T3 rectal cancer patients. Br J Radiol 2018;91:20170617. [PMID: 29072488 DOI: 10.1259/bjr.20170617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
45 Verseveld M, de Graaf EJ, Verhoef C, van Meerten E, Punt CJ, de Hingh IH, Nagtegaal ID, Nuyttens JJ, Marijnen CA, de Wilt JH. Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study). Br J Surg. 2015;102:853-860. [PMID: 25847025 DOI: 10.1002/bjs.9809] [Cited by in Crossref: 114] [Cited by in F6Publishing: 87] [Article Influence: 16.3] [Reference Citation Analysis]
46 Burbach JP, den Harder AM, Intven M, van Vulpen M, Verkooijen HM, Reerink O. Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis. Radiother Oncol. 2014;113:1-9. [PMID: 25281582 DOI: 10.1016/j.radonc.2014.08.035] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 8.9] [Reference Citation Analysis]